Cover Image
Market Research Report

European Life Sciences Key IT Deals and Initiatives Update, Q4 2019

Published by IDC Product code 929241
Published Content info 10 Pages
Delivery time: 1-2 business days
Back to Top
European Life Sciences Key IT Deals and Initiatives Update, Q4 2019
Published: March 18, 2020 Content info: 10 Pages

This IDC Market Perspective provides IDC Health Insights' review of key IT deals, news, and digital initiatives in European life sciences and pharma in Q4 2019. In the evolving industry environment in Europe, it is critical for life sciences companies to closely follow the fast-moving trends and developments to promptly spot favorable opportunities and remain competitive. This is the sixth in the quarterly series of reports IDC Health Insights has released as it continues to provide in-depth research coverage of life sciences markets across Europe."European life sciences companies are exploring new ways to harness the potential of digital technology to offer innovative products and services that go beyond the traditional industry boundaries. Drug serialization and traceability regulatory requirements remain a major challenge for pharma supply chain actors, presenting significant opportunity for technology vendors targeting European markets, with opportunities extending beyond EU borders." - Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe.

Table of Contents
Product Code: EUR144611420

Executive Snapshot

Situation Overview

  • Expanding Pharma Beyond the Pill, the Rise of Patient Engagement
    • The Next Chapter in Therapeutics: Software as an "Active Ingredient"
    • Consumer Self-Testing and Smart Shopping
    • Vital Signs Monitoring and Early Sensing
  • Smart Systems for Medication Optimization and Treatment Compliance
    • Medication Adherence Monitoring
    • Smart and Intelligent Drug Delivery
  • Advancing Medical Diagnostics
  • Transforming Life Sciences R&D, Turning Data into a Strategic Asset
    • Accelerating Drug Discovery, Advancing Personalized and Precision Medicine
    • Supporting Drug Clinical Development
  • Supporting Innovation Acceleration Programs
  • Upgrading Supply Chains: Drug Serialization and Traceability

Advice for the Technology Buyer

Learn More

  • Related Research
  • Synopsis
Back to Top